Cardiology Today


The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents

2017: Guidelines take prominence; much less focus on new drug discoveries

Carl J. Pepine, MD, MACC

Cardiology Today Anniversary

2 decades of intervention

Cardio-Oncology Corner

CVD in cancer survivors: Stick to the basics of prevention

Kristopher Swiger, MD

Cover Story

New guideline widens hypertension definition, incorporates CV risk

FDA News

FDA approves evolocumab for prevention of MI, stroke, coronary revascularization

In the Journals

Higher thyroid hormone levels linked to atherosclerotic CVD, mortality

Peripartum cardiomyopathy more common in black women

Exercise confers benefit in HFpEF

Perioperative myocardial injury common from noncardiac surgery

Noninvasive radioablation reduces burden in ventricular tachycardia

HYDRA: Rosuvastatin reduces LDL in children with homozygous FH

Increased levels of any physical activity reduce mortality, CVD risk

Abdominal obesity confers mortality risk in HFpEF

ACC advises on bleeding episodes with oral anticoagulants

CV health screenings rose after implementation of ACA

Afternoon surgical AVR confers fewer cardiac events

ECG abnormalities common in NBA athletes

Industry News

Looking ahead: Top trends for 2018

Cardiology Today asked the Editorial Board for their thoughts on the top stories of 2017

Meeting News

PRESERVE: No benefit of sodium bicarbonate, acetylcysteine for prevention of mortality, renal outcomes after angiography

Telepharmacy intervention yields modest effect on medication adherence among patients with cardiometabolic diseases

STEMI Accelerator-2: Coordinated emergency systems of care reduce treatment times, mortality

Ralinepag improves pulmonary vascular resistance in PAH

Burnout common in cardiologists, especially women

Evolocumab effective regardless of PAD, MI status

Pharmacology Consult

ICHECK’D: Mnemonic approach assists in caring for patients receiving direct oral anticoagulant

Deborah DeCamillo, RN, BSN; Elizabeth Renner, PharmD

Trial Scorecards

Trial Scoreard: DECIDE-LVAD

Trial Scoreard: CRESCENT-II

Trial Scoreard: PREMIUM

Trial Scoreard: HEROIC

Trial Scoreard: ALPS

Trial Scoreard: ATTRACT

Trial Scoreard: BRUISE CONTROL-2

Trial Scoreard: PRESERVE


A tribute to Emile Mohler, MD

Andrew E. Epstein, MD, FAHA, FACC, FHRS